[Cyclophosphamide and bladder carcinoma (case report) (author's transl)].
A bladder carcinoma developed in a 40-year-old man who was being treated with trofosfamide (Ixoten), a cyclophosphamide derivative, for Hodgkin's disease. The case suggests the need for differentiated replacement of this group of cytostatics.
D000328:Adult; D003520:Cyclophosphamide / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006417:Hematuria / Q000150:complications; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D008297:Male; D001749:Urinary Bladder Neoplasms / Q000139:chemically induced* / Q000150:complications / Q000601:surgery
D003520:Cyclophosphamide
Cyclophosphamid und Harnblasenkarzinom.